BackBiolase Overview

Biolase Inventory

Latest inventory for BIOL: $9.9M.

Get informed when a big investor buys or sells

+ Follow
Inventory
$9.87M
↓ 28.60% YoYΔ $-3.95M vs prior year quarter

Peer trimmed avg / median

Loading

Biolase Inventory History

Loading

Biolase vs. peers: Inventory Comparison

Loading

Biolase Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Biolase (BIOL) FAQ

As of the most recent data (September 2024), BIOL shows a inventory of $9.9M. That compares with $14M in the prior-year period — down 28.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BIOL's inventory is now $9.9M (was $14M) — a 28.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Biolase is outperforming or lagging.

Tracking BIOL's inventory over time shows whether Biolase is scaling, shrinking, or reshaping that part of the business. The current reading is $9.9M That compares with $14M in the prior-year period — down 28.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has Biolase's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $9.9M) with ownership activity and broader fundamentals.

Biolase's inventory is $9.9M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.